Chemed (MEX:CHE) Cyclically Adjusted Revenue per Share: MXN3,119.70 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CHE Chemed Corp MEX:CHE
88 GF Score
Price MXN9,083.33
GF Value MXN11,189.12
! 8 Warning Signs
View Full Analysis

What is Chemed Cyclically Adjusted Revenue per Share?

Chemed MEX:CHE 88 Cyclically Adjusted Revenue per Share is MXN3,119.70 as of Jun. 2026. GuruFocus rates MEX:CHE with a GF Score™ of 88/100 and a GF Value™ of MXN11,189.12. The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Chemed's adjusted revenue per share for the three months ended in Jun. 2026 was MXN890.034. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN3,119.70 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Chemed's average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Chemed was 14.00% per year. The lowest was -4.00% per year. And the median was 8.60% per year.

As of today (2026-08-08), Chemed's current stock price is MXN9083.33. Chemed's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN3,119.70. Chemed's Cyclically Adjusted PS Ratio of today is 2.91.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.88. And the median was 3.98.


Chemed  (MEX:CHE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chemed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9083.33/3119.70
=2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.88. And the median was 3.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Chemed Cyclically Adjusted Revenue per Share Related Terms


Chemed Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Chemed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemed Cyclically Adjusted Revenue per Share Chart

Chemed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 3,084.11 3,222.03

Chemed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,767.18 3,056.85 3,222.03 3,758.47 3,119.70

MEX:CHE vs PACS, LFST, UHS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Chemed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemed Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chemed's Cyclically Adjusted PS Ratio falls into.


MEX:CHE
88GF Score
Chemed Corp MEX:CHE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chemed's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=890.034/333.9520*333.9520
=890.034

Current CPI (Jun. 2026) = 333.9520.

Chemed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 458.437 241.428 634.127
201612 501.022 241.432 693.020
201703 454.855 243.801 623.048
201706 468.620 244.955 638.879
201709 454.292 246.819 614.668
201712 504.390 246.524 683.268
201803 472.480 249.554 632.271
201806 516.412 251.989 684.382
201809 495.340 252.439 655.286
201812 537.207 251.233 714.084
201903 542.362 254.202 712.516
201906 553.044 256.143 721.043
201909 573.136 256.759 745.446
201912 594.654 256.974 772.786
202003 732.286 258.115 947.440
202006 707.983 257.797 917.126
202009 712.796 260.280 914.552
202012 649.414 260.474 832.609
202103 660.930 264.877 833.288
202106 658.039 271.696 808.821
202109 699.159 274.310 851.174
202112 715.837 278.802 857.437
202203 695.350 287.504 807.688
202206 707.329 296.311 797.182
202209 704.028 296.808 792.133
202212 707.956 296.797 796.583
202303 668.222 301.836 739.322
202306 623.863 305.109 682.839
202309 646.942 307.789 701.934
202312 651.475 306.746 709.256
202403 637.529 312.332 681.660
202406 715.795 314.175 760.854
202409 786.912 315.301 833.460
202412 890.724 315.605 942.504
202503 896.457 319.799 936.131
202506 792.455 322.561 820.440
202509 795.565 324.800 817.982
202512 823.029 324.054 848.168
202603 866.087 330.213 875.894
202606 890.034 333.952 890.034

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN3,119.70 mean?
Chemed (MEX:CHE) has a Cyclically Adjusted Revenue per Share of MXN3,119.70 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Chemed and its competitors.
Is Chemed's Cyclically Adjusted Revenue per Share too high?
Chemed's current Cyclically Adjusted Revenue per Share is MXN3,119.70. Overall, Chemed has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Chemed's Cyclically Adjusted Revenue per Share compare to PACS and LFST?
Chemed's Cyclically Adjusted Revenue per Share of MXN3,119.70 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Chemed and its competitors. Chemed's current Cyclically Adjusted Revenue per Share is MXN3,119.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemed stock overvalued right now?
Chemed (MEX:CHE) has a current Cyclically Adjusted Revenue per Share of MXN3,119.70. The stock's GF Value™ is MXN11,189.12, compared to a current price of MXN9,083.33 — trading 18.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN3,119.70. Chemed's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Chemed (MEX:CHE), the current Cyclically Adjusted Revenue per Share is MXN3,119.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemed (MEX:CHE) Overvalued in 2026?

Based on GuruFocus' analysis, Chemed stock appears to be undervalued. The current stock price of MXN9,083.33 is trading 18.8% below its estimated GF Value™ of MXN11,189.12.

Key valuation signals for MEX:CHE:

  • Cyclically Adjusted Revenue per Share: MXN3,119.70
  • GF Value™: MXN11,189.12 vs. price of MXN9,083.33 (18.8% below fair value)
  • GF Score™: 88/100 with 8 warning signs

No single metric tells the full story. See the MEX:CHE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemed Business Description

Address 255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
88GF Score

Get the complete analysis for MEX:CHE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN9,083.33
Price
MXN11,189.12
GF Value